Corrigendum: Modularized Perturbation of Alternative Splicing Across Human Cancers

Front Genet. 2019 Oct 3:10:969. doi: 10.3389/fgene.2019.00969. eCollection 2019.

Yabing Du¹, Shoumiao Li², Ranran Du³, Ni Shi⁴, Seiji Arai^{5

6}, Sai Chen⁷, Aijie Wang⁷, Yu Zhang⁸, Zhaoyuan Fang⁹, Tengfei Zhang^{1

10}, Wang Ma^{1

10}

¹ Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
² Department of Surgery, Anyang Tumor Hospital, Anyang, China.
³ Institute of Medical Information, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
⁴ Comprehensive Cancer Center, Ohio State University, Columbus, OH, United States.
⁵ Department of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
⁶ Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
⁷ Department of Clinical Medicine, Xinxiang Medical University, Xinxiang, China.
⁸ Bioinformatics Group, Medcurius Co., Zhejiang, China.
⁹ Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, China.
¹⁰ Medical College, Henan Polytechnic University, Jiaozuo, China.

Abstract

[This corrects the article DOI: 10.3389/fgene.2019.00246.].

Keywords: alternative splicing; cancer splicing; prognosis; splicing modules; splicing network.